Crystal Bio Solutions logo

Sep 18, 2025

Receptor Occupancy of an Antibody Drug Measured by Flow Cytometry

Case study: a flow cytometry PD-1 receptor occupancy assay in the occupied format with total receptor normalization, CV below 8% and 3-day sample stability.

Receptor Occupancy of an Antibody Drug Measured by Flow Cytometry\

Summary: Crystal Bio Solutions established a flow cytometry receptor occupancy (RO) assay for PD-1 in whole blood using the occupied format, with simultaneous measurement of total receptor. Intra-run CV was 0.78–7.26% and inter-run CV 5.59–7.21% across quality control levels.

Objective

RO assays measure how much of a therapeutic antibody is bound to its target receptor and are used as pharmacodynamic biomarkers in clinical development. PD-1 regulates T-cell exhaustion, and blocking the PD-1 pathway can restore T-cell function. This study established a method to quantify PD-1 occupancy by its therapeutic antibody and assessed its suitability for clinical samples.

Challenges

  • Sensitivity depends on receptor expression level and on the affinity between the antibody and the receptor.
  • Receptor shedding or internalization can occur, and the stability of the antibody–receptor complex is the main practical issue for RO assays.
  • RO can be measured as free, bound (occupied) or total receptor; the best format depends on the therapeutic and on reagent availability.
Three receptor occupancy assay formats: free, occupied and total receptor
Figure 1. Three RO assay formats. (A) Free receptor: detection antibody competes with the drug. (B) Occupied receptor: non-neutralizing anti-idiotype detection. (C) Total receptor: detection antibody does not compete with the drug.

Approach

Because the PD-1/anti-PD-1 interaction is dynamic and varies between individuals, and a detection antibody that competes with the drug was not practical, the occupied format was used. Total receptor was measured in parallel by adding excess drug to a second aliquot, which normalizes for baseline expression. Bound drug was detected with a PE-conjugated detection antibody.

PD-1 receptor occupancy flow cytometry workflow and gating
Figure 2. RO assay workflow. Whole blood is tested without added drug (occupied) and with excess drug (total), stained with a PE-conjugated detection antibody and gated on lymphocytes, total T cells and CD8+ T cells. RO% = MFI(occupied) / MFI(total).

Results

RO was calculated as the ratio of the median fluorescence intensity (MFI) of occupied receptor to that of total receptor. The assay showed good intra- and inter-run precision and a drug-dependent linear range. RO samples were stable for 3 days after blood collection.

Precision of the occupied PD-1 RO assay
LevelIntra-run CV%Inter-run CV%
HQC (~100% RO)2.37–7.267.21
MQC (~50% RO)1.19–5.325.59
LQC (~0% RO)0.78–5.315.87
PD-1 receptor occupancy percentage versus drug concentration
Figure 3. PD-1 occupancy (%) versus drug concentration.

Conclusions

A PD-1 RO assay in the occupied format was established. Measuring total receptor at the same time accounts for baseline expression and reduces bias when receptor levels change during treatment. RO data can also help interpret the effect of ADA on PK and PD in nonclinical and clinical development.

Related services: Receptor occupancy assays · Bioanalysis and biomarkers.

Download the case study

Fill in the short form below and we will email you the PDF (2 pages, 1.3 MB).

To discuss a similar study, email cbs_bd@crystalpharmatech.com or call +1 925-558-5040.